3
Views
5
CrossRef citations to date
0
Altmetric
Original Article

The Presence of Autoantibody to Lipocortin-I in Autoimmune-Prone Mrl Mice

, , , , &
Page 239 | Published online: 07 Jul 2009

References

  • Peers S. H., Flower R. J. The role of lipocortin in corticosteroid actions. Am Rev Respir Dis 1990; 141: s18–s21
  • Hirata F., Carmine R. D., Nelson C. A., Axelrod J., Schiffmann E., Warabi A., Bias A. L. D., Nirenberg M., Mangniello V., Vaughan M., Kumagai S., Green I., Decker J. L., Steinberg A. D. Presence of autoantibody for phospholipase inhibitory protein, lipomo-dulin, in patients with rheumatic diseases. Proc Natl Acad Set USA 1981; 78: 3190–3194
  • Goulding N. J., Podgorski M. R., Hall N. D., Flower R. J., Browning J. L., Pepinsky R. B., Maddison P. J. Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 843–850
  • Ohshio G., Furukawa F., Yoshioka H., Taki Y., Manabe T., Ozawa K., Tobe T., Hamashima Y. High levels of anti-mito-chondrial antibodies in MRL mice. Microbiol Immunol 1987; 31: 75–81
  • Ando Y., Imamura S., Hong Y. M., Owada M. K., Kakunaga T., Kannagi R. Enhancement of calcium sensitivity of lipocortin I in phospholipid binding induced by limited proteolysis and phosphorylation at the amino terminus as analyzed by phospholipid affinity column chromatography. J Biol Chem 1989; 264: 6948–6955

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.